Health2047 expands its advisory board with strategic appointments
Group of accomplished business and healthcare leaders bring deep and diverse experience to AMA’s innovation subsidiary
MENLO PARK, Calif., June 30, 2022–(BUSINESS WIRE)–Health2047 Inc., the Silicon Valley innovation arm of the American Medical Association (AMA), has named several new doctors, Sameer Badlani, Arthur Combs and Mira Irons, to its advisory board . These three industry veterans bring considerable expertise and new perspectives to solving the biggest challenges in the healthcare system.
Health2047 helps early-stage startups turn bold ideas into healthy returns. Its portfolio companies provide system-level solutions in three areas: data, chronic disease and productivity. With deep expertise and diverse experiences in specialties ranging from artificial intelligence to market adoption strategies, information technology, public health and hospital operations, Health2047 works with its advisors to shape businesses with the best health system solutions that improve the way physicians and patients interact in the service of better health outcomes and improved physician satisfaction.
“To address the biggest challenges in healthcare, we are working closely with the physician community and technology leaders,” said Lawrence K. Cohen, CEO of Health2047. “We rely on our advisors to help us cultivate powerful ideas and connect with industry partners ready to take on the challenge of systemic healthcare transformation. The vast knowledge and experience of experts industry professionals like Drs. Badlani, Combs and Irons will undoubtedly help Health2047 accelerate both market innovation and impact.”
Joining Health2047 in its mission to transform American healthcare at the system level are:
Sameer Badlani, MD, FACP: Dr. Badlani is a physician executive and digital transformation leader who leverages his experience as both a clinician and a technology executive to transform the consumer experience of healthcare and wellness delivery. . As CDO of M Health Fairview, he focuses on large-scale operational innovation, maximizing digital technologies and improving processes to drive better business and clinical outcomes. He is an Adjunct Professor at Carnegie Mellon University for Executive Education Programs, was recognized in Crain’s 40 Under 40s, and was named to Becker’s list of top CDOs and CIOs in the healthcare system. Dr. Badlani also sits on the boards of the Network of Digital Evidence (NODE Health) and Carnegie Mellon’s Center for Machine Learning in Health. He received his medical degree from the University of Delhi in India, completed his residency in internal medicine and served as chief resident at the University of Oklahoma.
Arthur Combs, MD, FCCP, FCCM: Dr. Combs is an executive physician and serial entrepreneur. After more than 20 years of clinical practice, he spent the next two decades bringing new medical technologies to market as the leader of five successful start-ups and as a senior Fortune 500 executive. He focused on technologies non-invasive, although he has consulted across the spectrum of life sciences, from pharmaceuticals to biotechnology, proteomics, molecular diagnostics and medical devices. Dr. Combs was previously Chief Marketing Officer of MC10 Inc., a company positioned to revolutionize clinical trials and chronic disease management through wearable technology. He holds two honorary fellowships, two US patents and is the author of numerous original scientific articles, abstracts, editorials and book chapters. Dr. Combs is a graduate of the University of Notre Dame and received his medical degree from New York Medical College.
Mira Irons, MD: Dr. Irons is President and CEO of the College of Physicians of Philadelphia. She is the first woman to hold this position in the organization’s 235-year history. Prior to this role, she was Chief Health and Science Officer and Group Vice President, Health, Science, and Ethics at the American Medical Association (AMA). Dr. Irons is a Board Certified Physician in Clinical and Biochemical Genetics and Pediatrics. She also served as Senior Vice President for Academic Affairs at the American Board of Medical Specialties. Dr. Irons spent 30 years in academic medicine in Boston at Tufts Medical Center and most recently at Boston Children’s Hospital; she has also held various positions at Harvard, including residency director for medical genetics, fellowship director for laboratory genetics programs, and associate professor of pediatrics at Harvard Medical School. She received her medical degree from the Feinberg School of Medicine at Northwestern University.
The new advisors will join current advisory board members Steve Bochner, Gary Cookhorn, Francis J. (Jay) Crosson, MD, Charles Hoyng, Ph.D., Joe Marks, Ph.D., Georgia Papathomas, Ph.D., Cheryl Rucker-Whitaker, MD, Allison Spinner, Walter Stewart, Ph.D., Craig Taylor, Robert Wah, MD, Stephen Wong, Ph.D., and Eric Yablonka. “Our executives and advisors are committed to pioneering solutions that will shape the next generation of healthcare,” Cohen said. “We are extremely proud and honored to have such an accomplished group of health technology leaders on our advisory board.”
Health2047 Inc. is the Silicon Valley innovation arm of the American Medical Association committed to enabling fundamental transformation of healthcare in the United States. Health2047 invests in the future of healthcare by helping entrepreneurs turn big ideas into healthy returns for their businesses, investors and communities in the areas of data, chronic disease and productivity. Powered by the AMA, Health2047’s close relationships with its network of strategic partners create a unique force multiplier that helps drive informed, large-scale change in healthcare. For more information, please visit www.health2047.com.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220630005278/en/
Sterling Communications, Inc.